Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver
Clinical trial NCT07364474 · RECRUITING
Trial details
- NCT number
- NCT07364474
- Sponsor
- Massachusetts General Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-27
- Primary completion
- 2027-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.